Registrarse | Entrar  
 Buscar  
Novedades Minimizar
Junta Directiva 2009-2011
Presidente: Dra. María José Jannaut P. Secretaria: Dra. Rita Sierra M. Tesorero: Dr. Paul Mendez Patarroyo  

Nueva dirección electrónica de la Asociación Colombiana de Reumatología

asoreuma1@une.net.co y nuevo Telefax: 57 1 6350840 - 6350841  
Bienvenidos al nuevo sitio web de la ACR!
Este sistema tiene como fin estrechar la interacción entre los miembros de la asociación a través de la web.   ver más...
¡Descubra el nuevo software de clinimetría de la ACR!
Con CliniMetrix 1.0 se puede aplicar una variedad de instrumentos de valoración a los pacientes de forma rápida y sencilla.   ver más...
    
Sólo miembros Minimizar
    
Usuarios en línea Minimizar
Tipo de Miembro Tipo de Miembro:
Último nuevo usuario Último: YUREIDYS
Nuevos Hoy Nuevos Hoy: 0
Nuevos Ayer Nuevos Ayer: 0
Cantidad de usuarios En total: 464

Gente en línea Gente en línea:
Visitantes Visitantes: 1
Miembros Miembros: 0
Total Total: 1

En línea Ahora En línea ahora:
  
 

Google
    

Otras noticias

  Minimizar

ADELPHI, Md. (MedPage Today) -- An FDA advisory committee voted 25-10 to reject the agency's proposed plan to prevent inappropriate prescribing, misuse, and abuse of extended-release opioid painkillers, saying the plan lacks the teeth to stem the "public health crisis" of opioid addiction, overdose, and death.
ADELPHI, Md. (MedPage Today) -- An FDA advisory committee voted 25-10 to reject the agency's proposed plan to prevent inappropriate prescribing, misuse, and abuse of extended-release opioid painkillers, saying the plan lacks the teeth to stem the "public health crisis" of opioid addiction, overdose, and death.
(MedPage Today) -- Older patients with inflammatory arthritis are not receiving the full range of age-related preventive care they need, despite their being at increased risk for cardiovascular events, infection, and osteoporosis, a new study found.
(MedPage Today) -- Older patients with inflammatory arthritis are not receiving the full range of age-related preventive care they need, despite their being at increased risk for cardiovascular events, infection, and osteoporosis, a new study found.
(MedPage Today) -- A total joint replacement registry begun in California in 2001 has enhanced patient safety and quality of care by tracking implant performance and outcomes, according to a new report.
(MedPage Today) -- A total joint replacement registry begun in California in 2001 has enhanced patient safety and quality of care by tracking implant performance and outcomes, according to a new report.
WASHINGTON (MedPage Today) -- An FDA advisory panel will meet this week to vote on whether to adopt a new risk-reduction strategy for long-acting opioid-based painkillers, the use -- and misuse -- of which have exploded in recent years.
WASHINGTON (MedPage Today) -- An FDA advisory panel will meet this week to vote on whether to adopt a new risk-reduction strategy for long-acting opioid-based painkillers, the use -- and misuse -- of which have exploded in recent years.
(MedPage Today) -- Obesity in early adulthood is an independent risk factor for the development of psoriatic arthritis, a large case series found.
(MedPage Today) -- Obesity in early adulthood is an independent risk factor for the development of psoriatic arthritis, a large case series found.
(MedPage Today) -- Varicella vaccine appears to be safe and relatively immunogenic for use in children with rheumatic diseases being treated with immunosuppressive drugs, a small prospective study has found.
(MedPage Today) -- Varicella vaccine appears to be safe and relatively immunogenic for use in children with rheumatic diseases being treated with immunosuppressive drugs, a small prospective study has found.
(MedPage Today) -- New Canadian recommendations on the use of methotrexate in rheumatoid arthritis focus on routine clinical practice concerns -- ranging from drug interactions to clinical response and patient participation in therapeutic decision-making.
(MedPage Today) -- New Canadian recommendations on the use of methotrexate in rheumatoid arthritis focus on routine clinical practice concerns -- ranging from drug interactions to clinical response and patient participation in therapeutic decision-making.
(MedPage Today) -- Treatment with adalimumab was effective for both joint and skin manifestations of psoriatic arthritis in patients whose disease had not responded adequately to prior therapy, a multicenter open-label study found.
(MedPage Today) -- Treatment with adalimumab was effective for both joint and skin manifestations of psoriatic arthritis in patients whose disease had not responded adequately to prior therapy, a multicenter open-label study found.
(MedPage Today) -- Certain clinical features such as polyarthritis and elevated erythrocyte sedimentation rate lessen the likelihood that patients with psoriatic arthritis will achieve sustained minimal disease activity, an observational cohort study suggested.
(MedPage Today) -- Certain clinical features such as polyarthritis and elevated erythrocyte sedimentation rate lessen the likelihood that patients with psoriatic arthritis will achieve sustained minimal disease activity, an observational cohort study suggested.
(MedPage Today) -- For cancer patients, regular telemonitoring with a nurse-physician team, along with home symptom monitoring, can cut pain and depression, researchers say.
(MedPage Today) -- For cancer patients, regular telemonitoring with a nurse-physician team, along with home symptom monitoring, can cut pain and depression, researchers say.
WASHINGTON (MedPage Today) -- The FDA has expanded the black box warning to the label of the rheumatoid arthritis drug leflunomide (Arava) to include possible fatal liver damage.
WASHINGTON (MedPage Today) -- The FDA has expanded the black box warning to the label of the rheumatoid arthritis drug leflunomide (Arava) to include possible fatal liver damage.
  
  Minimizar
The remote server returned an error: (404) Not Found.

  
  Minimizar

Copyright © 2001-2006 The Doctors Lounge. All rights reserved.
Vioxx found to double the risk of developing a cardiovascular "event" when compared to placebo.
Vioxx found to double the risk of developing a cardiovascular "event" when compared to placebo.